한국어판 말장애지수(The Korean Version of Speech Handicap Index)에 대한 예비연구

A Pilot Study of the Korean Version of Speech Handicap Index (SHI)

  • 박성신 (서울대학교병원 언어청각장애진료실) ;
  • 최성희 (대구가톨릭대학교 언어청각치료학과) ;
  • 차원재 (서울대학교병원 이비인후과) ;
  • 홍영혜 (서울대학교병원 언어청각장애진료실) ;
  • 정년기 (서울대학교병원 언어청각장애진료실) ;
  • 성명훈 (서울대학교병원 이비인후과) ;
  • 하정훈 (서울대학교병원 이비인후과)
  • Park, Sung Shin (Department of Speech & Hearing Clinic, Seoul National University Hospital) ;
  • Choi, Seong Hee (Department of Audiology and Speech-Language Pathology, Catholic University of Deagu) ;
  • Cha, Wonjae (Department of Otorhinolaryngology, Seoul National University Hospital) ;
  • Hong, Young Hye (Department of Speech & Hearing Clinic, Seoul National University Hospital) ;
  • Jeong, Nyun Gi (Department of Speech & Hearing Clinic, Seoul National University Hospital) ;
  • Sung, Myung-Whun (Department of Otorhinolaryngology, Seoul National University Hospital) ;
  • Hah, J. Hun (Department of Otorhinolaryngology, Seoul National University Hospital)
  • 투고 : 2013.05.06
  • 심사 : 2013.05.23
  • 발행 : 2013.06.30

초록

Background & Objectives : The Speech Handicap Index (SHI) is used to assess speech problem of head and neck cancer patients. The aim of this preliminary study was to evaluate the reliability and validity the Korean version SHI. Materials and Methods : Sixteen patients with oral cavity cancer and 26 normal control were participated in the study. Test-retest reliability of the Korean version of SHI was completed by 20 out of 42 subjects after 2weeks. Mann-Whitney U test was used to compare the Korean version of SHI scores between normal population and patients group. The relationship between the Korean version of SHI and diadochokinesis (DDK) was investigated using Spearman correlation coefficients. Results : The Korean version of SHI provided a high internal consistency (${\alpha}$=0.99) and test-retest reliability (Spearman rho 0.98). The mean SHI scores [total (T), speech (S), and psychosocial (P)] in normal population were 0.8 (T), 0.2 (S) and 0.4 (P), whereas those in patients group were 58.1 (T), 27.9 (S) and 27.0 (P) respectively. There were significant differences in total SHI score as well as in all of the sub-SHI scores between two groups. Moreover, significant correlation between the Korean version of SHI parameters (T, S, P) and sequential motion rate (SMR) were yielded in patients group. Conclusion : The Korean version of SHIwas reliable and valid. It can be useful as a supplementary clinical tool for diagnosing and measuring treatment efficacy of speech problems related to oral cavity cancer.

키워드